MarketLens
Sign Up

What Does the Alnylam-Inceptive AI Deal Entail

2 months ago
SHARE THIS ON:

What Does the Alnylam-Inceptive AI Deal Entail

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News12 hours ago

EXCLUSIVE: Nvidia GPUs Are Essential—But They Won't Decide Who Wins AI Drug Discovery, Generate CTO Says

Nvidia's GPUs underpin AI but won't decide AI drug discovery winners, per Generate Biomedicines' CTO. Compute access is necessary, yet differentiation will hinge on proprietary data and algorithms, no...
Stock News12 hours ago

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays

Monod Bio licensed AI-designed protein technologies to SignalChem Biotech for custom discovery assays. The deal expands SignalChem's assay capabilities and Monod Bio's commercial reach, though financi...
Stock News1 months ago

Biotech's takeover boom may be running out of buyers

Biotech deal value hit $78B in H1 2026, nearly double 2025's full-year $42B total. RBC Capital Markets warns the pace is unlikely to hold, suggesting a slowdown ahead.
Stock News1 months ago

Can Alnylam's Drug Pipeline Fuel Its Long-Term Revenue Growth?

Alnylam's pipeline and partnered programs could expand future revenue sources beyond its growing approved therapy portfolio.

Breaking News

View All →

Top Headlines

View More →
Stock News39 minutes ago

NVIDIA Reports +120% Earnings Growth: Ho-Hum, Just Another Day

Stock News47 minutes ago

INTU FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Intuit Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 8 Deadline in Securities Class Action Filed by the Firm- INTU

Stock News53 minutes ago

NVIDIA Q2 Earnings Call Highlights

Stock News1 hour ago

Nvidia forecasts quarterly revenue above estimates, shares rise

Stock News1 hour ago

CEO Jensen Huang went on an AI deal spree in August. Nvidia plans to invest $18 billion more this fiscal year.